CAS: 931117-61-2; (S)-2-(2-((4-(5-((5-Chlorothiophene-2-Carboxamido)Methyl)-2-Oxooxazolidin-3-yl)Phenyl)Amino)Ethoxy)Acetic Acid Hydrochloride

结构式图片

MSDS等安全信息

    上下游产品

    Rivaroxaban 2-{2-[1-(5-chlorothiophen-2-yl)-N-{4-[(5S)-5-{[(5-chlorothiophen-2-yl)formamido]methyl}-2-oxo-1,3-oxazolidin-3-yl]phenyl}formamido]ethoxy}acetic acid 2-[2-({4-[(5S)-5-{[(5-chlorothiophen-2-yl)formamido]methyl}-2-oxo-1,3-oxazolidin-3-yl]phenyl}amino)ethoxy]acetic acid

    合成工艺路线路线简述

    • 366789-02-8 = 931117-61-2
      反应条件:1.1 Reagents: Hydrochloric Acid,Water Solvents: Acetic Acid,Water; Rt; Rt -> 70 °C; 5 - 6 H,70 °C; 70 °C -> Rt; 15 H,Rt
      标题:Preparation Of 2-Aminoethoxyacetic Acid Derivatives As Factor Xa Inhibitors For Treating Thromboembolic Diseases
      参考文献:Germany
    📜利伐沙班置于盐酸,水,溶剂黄146体系中,化学反应 6.0H,以76%的收率获得产物利伐沙班杂质25
    参考文献:2-Aminoethoxyacetic Acid Derivatives And Their Use
    标题:2-Aminoethoxyacetic Acid Derivatives And Their Use
    摘要:本申请涉及新型2-氨基乙氧基乙酸衍生物,其制备方法,其用于治疗和/或预防疾病以及用于制备用于治疗和/或预防疾病的药物,特别是血栓栓塞性疾病的用途.

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知